PHIO: Phio Pharmaceuticals Corp Financial Statements

Balance sheet, income statement, and cash flow statements for Phio Pharmaceuticals Corp (PHIO).

OverviewDividends

$1.90M Market Cap.

As of 05/17/2025 5:00 PM ET (MRY) • Disclaimer

PHIO Market Cap. (MRY)


PHIO Shares Outstanding (MRY)


PHIO Assets (MRY)


Total Assets

$5.74M

Total Liabilities

$1.01M

Total Investments

$0

PHIO Income (MRY)


Revenue

$0

Net Income

-$7.15M

Operating Expense

$7.39M

PHIO Cash Flow (MRY)


CF Operations

-$7.11M

CF Investing

$8.00K

CF Financing

$4.00M

PHIO Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$5,738,000 (-38.72%)

$9,364,000 (-26.92%)

$12,814,000 (-49.09%)

$25,170,000 (59.92%)

Assets Current

$5,736,000 (-38.47%)

$9,322,000 (-25.10%)

$12,446,000 (-49.67%)

$24,727,000 (63.06%)

Assets Non-Current

$2,000 (-95.24%)

$42,000 (-88.59%)

$368,000 (-16.93%)

$443,000 (-22.96%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$4,723,000 (-38.90%)

$7,730,000 (-28.68%)

$10,838,000 (-50.58%)

$21,932,000 (68.49%)

Property Plant & Equipment Net

$2,000 (-94.87%)

$39,000 (-88.66%)

$344,000 (-17.31%)

$416,000 (-25.31%)

Cash & Equivalents

$5,382,000 (-36.61%)

$8,490,000 (-28.24%)

$11,831,000 (-50.92%)

$24,107,000 (68.65%)

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$253,000 (-61.49%)

$657,000 (-15.66%)

$779,000 (175.27%)

$283,000 (-61.13%)

Accumulated Retained Earnings (Deficit)

-$146,356,000 (-5.14%)

-$139,206,000 (-8.43%)

-$128,380,000 (-9.82%)

-$116,900,000 (-12.82%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$0 (0%)

$35,000 (-79.41%)

$170,000 (-42.37%)

$295,000 (-54.05%)

Debt Current

$0 (0%)

$35,000 (-74.07%)

$135,000 (8.00%)

$125,000 (7.76%)

Debt Non-Current

$0 (0%)

$0 (0%)

$35,000 (-79.41%)

$170,000 (-67.68%)

Total Liabilities

$1,015,000 (-37.88%)

$1,634,000 (-17.22%)

$1,974,000 (-39.04%)

$3,238,000 (18.96%)

Liabilities Current

$1,015,000 (-37.88%)

$1,634,000 (-15.73%)

$1,939,000 (-36.80%)

$3,068,000 (39.71%)

Liabilities Non-Current

$0 (0%)

$0 (0%)

$35,000 (-79.41%)

$170,000 (-67.68%)

PHIO Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$3,744,000 (-14.25%)

$4,366,000 (-1.89%)

$4,450,000 (-3.78%)

$4,625,000 (-8.90%)

Research & Development Expense

$3,643,000 (-42.47%)

$6,332,000 (-9.70%)

$7,012,000 (-21.09%)

$8,886,000 (139.13%)

Operating Expenses

$7,387,000 (-31.75%)

$10,824,000 (-5.57%)

$11,462,000 (-15.17%)

$13,511,000 (53.66%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$7,150,000 (33.96%)

-$10,826,000 (5.70%)

-$11,480,000 (13.60%)

-$13,287,000 (-51.09%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$7,150,000 (33.96%)

-$10,826,000 (5.70%)

-$11,480,000 (13.60%)

-$13,287,000 (-51.09%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$7,150,000 (33.96%)

-$10,826,000 (5.70%)

-$11,480,000 (13.60%)

-$13,287,000 (-51.09%)

Weighted Average Shares

$787,466 (240.15%)

$231,508 (83.32%)

$126,285 (6.30%)

$118,804 (179.70%)

Weighted Average Shares Diluted

$787,466 (240.15%)

$231,508 (83.32%)

$126,285 (6.30%)

$118,804 (179.70%)

Earning Before Interest & Taxes (EBIT)

-$7,150,000 (33.96%)

-$10,826,000 (5.70%)

-$11,480,000 (13.60%)

-$13,287,000 (-51.11%)

Gross Profit

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Operating Income

-$7,387,000 (31.75%)

-$10,824,000 (5.57%)

-$11,462,000 (15.17%)

-$13,511,000 (-53.66%)

PHIO Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$8,000 (260.00%)

-$5,000 (95.87%)

-$121,000 (-137.25%)

-$51,000 (-168.42%)

Net Cash Flow from Financing

$3,996,000 (-46.09%)

$7,413,000 (28611.54%)

-$26,000 (-100.12%)

$21,722,000 (34.66%)

Net Cash Flow from Operations

-$7,112,000 (33.84%)

-$10,749,000 (11.38%)

-$12,129,000 (-2.29%)

-$11,858,000 (-34.72%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$3,108,000 (6.97%)

-$3,341,000 (72.78%)

-$12,276,000 (-225.10%)

$9,813,000 (34.24%)

Net Cash Flow - Business Acquisitions and Disposals

$9,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

-$1,000 (80.00%)

-$5,000 (95.87%)

-$121,000 (-137.25%)

-$51,000 (-168.42%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$4,001,000 (-46.23%)

$7,441,000 (0%)

$0 (0%)

$21,723,000 (36.37%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$147,000 (-51.49%)

$303,000 (-26.81%)

$414,000 (-13.75%)

$480,000 (252.94%)

Depreciation Amortization & Accretion

$35,000 (-80.98%)

$184,000 (-4.66%)

$193,000 (0.52%)

$192,000 (4.92%)

PHIO Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

-

-

-

-

Profit Margin

-

-

-

-

EBITDA Margin

-

-

-

-

Return on Average Equity (ROAE)

-150.20% (-11.51%)

-134.70% (-78.41%)

-75.50% (-52.53%)

-49.50% (18.18%)

Return on Average Assets (ROAA)

-120.40% (-13.69%)

-105.90% (-63.43%)

-64.80% (-44.64%)

-44.80% (12.84%)

Return on Sales (ROS)

-

-

-

-

Return on Invested Capital (ROIC)

986.50% (11.26%)

886.70% (-43.90%)

1580.70% (-2.86%)

1627.30% (-66.55%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-0.2 (-35.62%)

-0.15 (66.97%)

-0.44 (54.20%)

-0.96 (31.12%)

Price to Sales Ratio (P/S)

-

-

-

-

Price to Book Ratio (P/B)

0.4 (67.50%)

0.24 (-48.83%)

0.47 (-23.99%)

0.62 (-48.37%)

Debt to Equity Ratio (D/E)

0.21 (1.90%)

0.21 (15.93%)

0.18 (22.97%)

0.15 (-29.19%)

Earnings Per Share (EPS)

-9.08 (80.58%)

-46.76 (48.56%)

-90.91 (18.74%)

-111.87 (46.05%)

Sales Per Share (SPS)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-9.03 (80.55%)

-46.45 (52.11%)

-97 (3.23%)

-100.24 (51.73%)

Book Value Per Share (BVPS)

6 (-82.04%)

33.39 (-61.09%)

85.82 (-53.51%)

184.61 (-39.76%)

Tangible Assets Book Value Per Share (TABVPS)

7.29 (-81.98%)

40.45 (-60.14%)

101.47 (-52.11%)

211.86 (-42.82%)

Enterprise Value Over EBIT (EV/EBIT)

0 (0%)

1 (0.00%)

1 (0.00%)

1 (0%)

Enterprise Value Over EBITDA (EV/EBITDA)

0.49 (-20.03%)

0.61 (-25.03%)

0.82 (-15.74%)

0.97 (1100.00%)

Asset Turnover

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Current Ratio

5.65 (-0.95%)

5.71 (-11.12%)

6.42 (-20.36%)

8.06 (16.73%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$7,113,000 (33.86%)

-$10,754,000 (12.21%)

-$12,250,000 (-2.86%)

-$11,909,000 (-35.01%)

Enterprise Value (EV)

-$3,490,606 (46.54%)

-$6,529,980 (29.39%)

-$9,247,514 (27.36%)

-$12,730,308 (-1720.68%)

Earnings Before Tax (EBT)

-$7,150,000 (33.96%)

-$10,826,000 (5.70%)

-$11,480,000 (13.60%)

-$13,287,000 (-51.09%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$7,115,000 (33.14%)

-$10,642,000 (5.71%)

-$11,287,000 (13.81%)

-$13,095,000 (-52.09%)

Invested Capital

-$659,000 (9.10%)

-$725,000 (7.76%)

-$786,000 (54.04%)

-$1,710,000 (-1468.81%)

Working Capital

$4,721,000 (-38.59%)

$7,688,000 (-26.83%)

$10,507,000 (-51.49%)

$21,659,000 (67.02%)

Tangible Asset Value

$5,738,000 (-38.72%)

$9,364,000 (-26.92%)

$12,814,000 (-49.09%)

$25,170,000 (59.92%)

Market Capitalization

$1,899,394 (2.28%)

$1,857,020 (-63.48%)

$5,084,486 (-62.43%)

$13,534,692 (-12.96%)

Average Equity

$4,761,500 (-40.77%)

$8,039,500 (-47.13%)

$15,204,750 (-43.38%)

$26,855,750 (84.61%)

Average Assets

$5,938,000 (-41.94%)

$10,226,500 (-42.31%)

$17,727,750 (-40.22%)

$29,656,500 (73.19%)

Invested Capital Average

-$724,750 (40.64%)

-$1,221,000 (-68.12%)

-$726,250 (11.05%)

-$816,500 (-351.73%)

Shares

1,055,219 (288.67%)

271,494 (114.53%)

126,555 (0.98%)

125,321 (134.14%)